Bank Of Montreal

Direxion Daily Small Cap Bull 3X ETF

SPDR S&P Retail ETF

ProShares UltraPro Dow30

ProShares UltraShort Bloomberg Natrl Gas

Guggenheim Solar ETF

Direxion Technology Bear 3X Shares

Materials Select Sector SPDR

ProShares Trust ProShares Short Bitcoin Strategy ETF

ProShares Bitcoin Strategy ETF

Direxion Daily Small Cap Bear 3X ETF

ProShares Ultra Bloomberg Natural Gas

Direxion Daily Technology Bull 3X ETF

ARK Innovation ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Magal Security Systems Ltd.

Direxion Financial Bear 3X Shar

Direxion Daily Semicondct Bull 3X ETF

JELD-WEN Holding Inc. Common Stock

Las Vegas Sands Corp. Common Stock

Century Communities Inc. Common Stock

Kontoor Brands Inc. Common Stock

Bath & Body Works Inc.

RLJ Lodging Trust Common Shares of Beneficial Interest $0.01 par value

Leggett & Platt Incorporated Common Stock

Snap Inc. Class A Common Stock

Cleveland-Cliffs Inc. Common Stock

Civitas Resources Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

AMC Entertainment Holdings Inc. Class A Common Stock

Oklo Inc.

QuantumScape Corporation Class A Common Stock

Sea Limited American Depositary Shares each representing one Class A Ordinary Share

Cameco Corporation Common Stock

Twilio Inc. Class A Common Stock

Spotify Technology S.A. Ordinary Shares

Cloudflare Inc. Class A Common Stock

Molina Healthcare Inc Common Stock

Click here to get full coverage on What insights do SCNX's 2023 earnings reveal about its stability? - AInvest

What insights do SCNX's 2023 earnings reveal about its stability?  AInvest

What insights do SCNX's 2023 earnings reveal about its stability? - AInvest

Click here to get full coverage on How many analysts rate SCNX as a “Buy” - Wealth Building Picks That Work - jammulinksnews.com

How many analysts rate SCNX as a “Buy” - Wealth Building Picks That Work  jammulinksnews.com

How many analysts rate SCNX as a “Buy” - Wealth Building Picks That Work - jammulinksnews.com

Click here to get full coverage on Scienture Meets $1 Nasdaq Requirement as FDA-Approved Drug Launch Approaches - Stock Titan

Scienture Meets $1 Nasdaq Requirement as FDA-Approved Drug Launch Approaches  Stock Titan

Scienture Meets $1 Nasdaq Requirement as FDA-Approved Drug Launch Approaches - Stock Titan

Click here to get full coverage on Key External Factors That Drive SCNX Stock Price Movements - Free Stock Market Forecasting Tools - metal.it

Key External Factors That Drive SCNX Stock Price Movements - Free Stock Market Forecasting Tools  metal.it

Key External Factors That Drive SCNX Stock Price Movements - Free Stock Market Forecasting Tools - metal.it

Click here to get full coverage on SCNX Stock Price and Chart — NASDAQ:SCNX - TradingView

SCNX Stock Price and Chart — NASDAQ:SCNX  TradingView

SCNX Stock Price and Chart — NASDAQ:SCNX - TradingView

Click here to get full coverage on How does SCNX generate profit in a changing economy - Get alerts on the hottest market movers - jammulinksnews.com

How does SCNX generate profit in a changing economy - Get alerts on the hottest market movers  jammulinksnews.com

How does SCNX generate profit in a changing economy - Get alerts on the hottest market movers - jammulinksnews.com

Click here to get full coverage on New Product Launches: Will They Boost SCNX Stock in 2025 - Market Momentum Signal Generator Shows Trends - metal.it

New Product Launches: Will They Boost SCNX Stock in 2025 - Market Momentum Signal Generator Shows Trends  metal.it

New Product Launches: Will They Boost SCNX Stock in 2025 - Market Momentum Signal Generator Shows Trends - metal.it

Click here to get full coverage on Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding - Stock Titan

Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding  Stock Titan

Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding - Stock Titan

Click here to get full coverage on How does SCNX compare to its industry peers - High-yield capital appreciation - jammulinksnews.com

How does SCNX compare to its industry peers - High-yield capital appreciation  jammulinksnews.com

How does SCNX compare to its industry peers - High-yield capital appreciation - jammulinksnews.com

Click here to get full coverage on What is SCNX company’s growth strategy - Triple-digit returns - jammulinksnews.com

What is SCNX company’s growth strategy - Triple-digit returns  jammulinksnews.com

What is SCNX company’s growth strategy - Triple-digit returns - jammulinksnews.com

Click here to get full coverage on What are SCNX company’s key revenue drivers - Capitalize on high-growth stocks early - jammulinksnews.com

What are SCNX company’s key revenue drivers - Capitalize on high-growth stocks early  jammulinksnews.com

What are SCNX company’s key revenue drivers - Capitalize on high-growth stocks early - jammulinksnews.com

Click here to get full coverage on Should I hold or sell SCNX stock in 2025 - Capitalize on market momentum for big wins - jammulinksnews.com

Should I hold or sell SCNX stock in 2025 - Capitalize on market momentum for big wins  jammulinksnews.com

Should I hold or sell SCNX stock in 2025 - Capitalize on market momentum for big wins - jammulinksnews.com

Click here to get full coverage on What is SCNX company’s growth strategy - Tremendous wealth creation - jammulinksnews.com

What is SCNX company’s growth strategy - Tremendous wealth creation  jammulinksnews.com

What is SCNX company’s growth strategy - Tremendous wealth creation - jammulinksnews.com

Click here to get full coverage on How does SCNX compare to its industry peers - Daily Trading Picks With High Returns - jammulinksnews.com

How does SCNX compare to its industry peers - Daily Trading Picks With High Returns  jammulinksnews.com

How does SCNX compare to its industry peers - Daily Trading Picks With High Returns - jammulinksnews.com

Click here to get full coverage on How does SCNX generate profit in a changing economy - Achieve rapid wealth accumulation with smart picks - jammulinksnews.com

How does SCNX generate profit in a changing economy - Achieve rapid wealth accumulation with smart picks  jammulinksnews.com

How does SCNX generate profit in a changing economy - Achieve rapid wealth accumulation with smart picks - jammulinksnews.com

Click here to get full coverage on What is the risk reward ratio of investing in SCNX stock - Get daily updates on the hottest stocks - jammulinksnews.com

What is the risk reward ratio of investing in SCNX stock - Get daily updates on the hottest stocks  jammulinksnews.com

What is the risk reward ratio of investing in SCNX stock - Get daily updates on the hottest stocks - jammulinksnews.com

Click here to get full coverage on What is the risk reward ratio of investing in SCNX stock - Build wealth steadily with proven investment techniques - jammulinksnews.com

What is the risk reward ratio of investing in SCNX stock - Build wealth steadily with proven investment techniques  jammulinksnews.com

What is the risk reward ratio of investing in SCNX stock - Build wealth steadily with proven investment techniques - jammulinksnews.com

Click here to get full coverage on What drives SCNX stock price - Explosive trading opportunities - PrintWeekIndia

What drives SCNX stock price - Explosive trading opportunities  PrintWeekIndia

What drives SCNX stock price - Explosive trading opportunities - PrintWeekIndia

Click here to get full coverage on Scienture Holdings Secures $1.2 Million in Capital Raise - MSN

Scienture Holdings Secures $1.2 Million in Capital Raise  MSN

Scienture Holdings Secures $1.2 Million in Capital Raise - MSN

Click here to get full coverage on What are analysts’ price targets for SCNX in the next 12 months - Daily Trading Recommendation To Watch Now - jammulinksnews.com

What are analysts’ price targets for SCNX in the next 12 months - Daily Trading Recommendation To Watch Now  jammulinksnews.com

What are analysts’ price targets for SCNX in the next 12 months - Daily Trading Recommendation To Watch Now - jammulinksnews.com

Click here to get full coverage on Major Pharma Transformation: Scienture Reveals Two FDA-Approved Drugs and $480M+ Market Opportunity - Stock Titan

Major Pharma Transformation: Scienture Reveals Two FDA-Approved Drugs and $480M+ Market Opportunity  Stock Titan

Major Pharma Transformation: Scienture Reveals Two FDA-Approved Drugs and $480M+ Market Opportunity - Stock Titan

Click here to get full coverage on SCNX’s Unexpected Leap: What’s Driving the Momentum?​ - StocksToTrade

SCNX’s Unexpected Leap: What’s Driving the Momentum?​  StocksToTrade

SCNX’s Unexpected Leap: What’s Driving the Momentum?​ - StocksToTrade

Click here to get full coverage on Is it time to cut losses on SCNX - Trend Analysis for Safer Trades Gains Popularity - metal.it

Is it time to cut losses on SCNX - Trend Analysis for Safer Trades Gains Popularity  metal.it

Is it time to cut losses on SCNX - Trend Analysis for Safer Trades Gains Popularity - metal.it

Click here to get full coverage on Is Scienture Holdings (NASDAQ:SCNX) Using Debt Sensibly? - simplywall.st

Is Scienture Holdings (NASDAQ:SCNX) Using Debt Sensibly?  simplywall.st

Is Scienture Holdings (NASDAQ:SCNX) Using Debt Sensibly? - simplywall.st

Click here to get full coverage on SCNX’s Unexpected Rise: What’s Behind It? - StocksToTrade

SCNX’s Unexpected Rise: What’s Behind It?  StocksToTrade

SCNX’s Unexpected Rise: What’s Behind It? - StocksToTrade

Click here to get full coverage on Scienture Holdings Secures $1.2 Million in Capital Raise - The Globe and Mail

Scienture Holdings Secures $1.2 Million in Capital Raise  The Globe and Mail

Scienture Holdings Secures $1.2 Million in Capital Raise - The Globe and Mail

Click here to get full coverage on Revolutionary Liquid Losartan Targets $292M Market: First FDA-Approved Formula Challenges Traditional Tablets - Stock Titan

Revolutionary Liquid Losartan Targets $292M Market: First FDA-Approved Formula Challenges Traditional Tablets  Stock Titan

Revolutionary Liquid Losartan Targets $292M Market: First FDA-Approved Formula Challenges Traditional Tablets - Stock Titan

Click here to get full coverage on What drives SCNX stock price - Dynamic investment growth - jammulinksnews.com

What drives SCNX stock price - Dynamic investment growth  jammulinksnews.com

What drives SCNX stock price - Dynamic investment growth - jammulinksnews.com

Click here to get full coverage on FDA Approves Revolutionary Liquid Losartan: Scienture's Game-Changing Hypertension Treatment - Stock Titan

FDA Approves Revolutionary Liquid Losartan: Scienture's Game-Changing Hypertension Treatment  Stock Titan

FDA Approves Revolutionary Liquid Losartan: Scienture's Game-Changing Hypertension Treatment - Stock Titan

Click here to get full coverage on SCNX Stock Surges: Triumph or Turbulence Ahead? - timothysykes.com

SCNX Stock Surges: Triumph or Turbulence Ahead?  timothysykes.com

SCNX Stock Surges: Triumph or Turbulence Ahead? - timothysykes.com

Click here to get full coverage on Dramatic Leap: SCNX Stock Surge Causes Stir - StocksToTrade

Dramatic Leap: SCNX Stock Surge Causes Stir  StocksToTrade

Dramatic Leap: SCNX Stock Surge Causes Stir - StocksToTrade

Click here to get full coverage on What markets is BEATW expanding into Is SCNX stock a good long term investment option - jammulinksnews.com

What markets is BEATW expanding into Is SCNX stock a good long term investment option  jammulinksnews.com

What markets is BEATW expanding into Is SCNX stock a good long term investment option - jammulinksnews.com

Click here to get full coverage on Is SCNX a good long term investment - Massive wealth growth - jammulinksnews.com

Is SCNX a good long term investment - Massive wealth growth  jammulinksnews.com

Is SCNX a good long term investment - Massive wealth growth - jammulinksnews.com

Click here to get full coverage on Is SCNX a good long term investment - Consistently superior profits - Autocar Professional

Is SCNX a good long term investment - Consistently superior profits  Autocar Professional

Is SCNX a good long term investment - Consistently superior profits - Autocar Professional

Click here to get full coverage on Can This New High-Strength Naloxone Treatment Transform the $189M Opioid Crisis Market? - Stock Titan

Can This New High-Strength Naloxone Treatment Transform the $189M Opioid Crisis Market?  Stock Titan

Can This New High-Strength Naloxone Treatment Transform the $189M Opioid Crisis Market? - Stock Titan

Click here to get full coverage on Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding - The Globe and Mail

Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding  The Globe and Mail

Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding - The Globe and Mail

Click here to get full coverage on Breakthrough FDA Approval: First-Ever Liquid Hypertension Drug Targets $1.5B Market - Stock Titan

Breakthrough FDA Approval: First-Ever Liquid Hypertension Drug Targets $1.5B Market  Stock Titan

Breakthrough FDA Approval: First-Ever Liquid Hypertension Drug Targets $1.5B Market - Stock Titan

Click here to get full coverage on Why SCNX stock attracts strong analyst attention - Free Predictions - beatles.ru

Why SCNX stock attracts strong analyst attention - Free Predictions  beatles.ru

Why SCNX stock attracts strong analyst attention - Free Predictions - beatles.ru

Click here to get full coverage on What is the dividend policy of SCNX stock - Invest smarter with cutting-edge analytics - jammulinksnews.com

What is the dividend policy of SCNX stock - Invest smarter with cutting-edge analytics  jammulinksnews.com

What is the dividend policy of SCNX stock - Invest smarter with cutting-edge analytics - jammulinksnews.com

Click here to get full coverage on SCNX stock touches 52-week low at $2 amid market challenges - Investing.com

SCNX stock touches 52-week low at $2 amid market challenges  Investing.com

SCNX stock touches 52-week low at $2 amid market challenges - Investing.com

Click here to get full coverage on Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements - The Globe and Mail

Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements  The Globe and Mail

Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements - The Globe and Mail

Click here to get full coverage on What drives SCNX stock price - Turbocharged investment results - PrintWeekIndia

What drives SCNX stock price - Turbocharged investment results  PrintWeekIndia

What drives SCNX stock price - Turbocharged investment results - PrintWeekIndia

Click here to get full coverage on SCNX - Scienture Holdings, Inc Latest Stock News & Market Updates - Stock Titan

SCNX - Scienture Holdings, Inc Latest Stock News & Market Updates  Stock Titan

SCNX - Scienture Holdings, Inc Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Why SCNX stock attracts strong analyst attention - Consistent Win Signals - metal.it

Why SCNX stock attracts strong analyst attention - Consistent Win Signals  metal.it

Why SCNX stock attracts strong analyst attention - Consistent Win Signals - metal.it

Click here to get full coverage on What analysts say about SCNX stock - Massive profits - Autocar Professional

What analysts say about SCNX stock - Massive profits  Autocar Professional

What analysts say about SCNX stock - Massive profits - Autocar Professional

Click here to get full coverage on Scienture Holdings Secures $62M in Strategic Financing, Including $12.2M Debenture Deal - Stock Titan

Scienture Holdings Secures $62M in Strategic Financing, Including $12.2M Debenture Deal  Stock Titan

Scienture Holdings Secures $62M in Strategic Financing, Including $12.2M Debenture Deal - Stock Titan

Click here to get full coverage on Scienture Holdings Terminates Agreement with Arena Business - TipRanks

Scienture Holdings Terminates Agreement with Arena Business  TipRanks

Scienture Holdings Terminates Agreement with Arena Business - TipRanks

Click here to get full coverage on Scienture Holdings Divests Subsidiaries to Tollo Health - TipRanks

Scienture Holdings Divests Subsidiaries to Tollo Health  TipRanks

Scienture Holdings Divests Subsidiaries to Tollo Health - TipRanks

Click here to get full coverage on SCNX Stock Analysis and Forecast - Free Consultation - jammulinksnews.com

SCNX Stock Analysis and Forecast - Free Consultation  jammulinksnews.com

SCNX Stock Analysis and Forecast - Free Consultation - jammulinksnews.com

Click here to get full coverage on Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041 - GlobeNewswire

Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041  GlobeNewswire

Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041 - GlobeNewswire

Click here to get full coverage on Scienture Secures Crucial Patent Protection for Novel Losartan Oral Suspension Through 2041 - Stock Titan

Scienture Secures Crucial Patent Protection for Novel Losartan Oral Suspension Through 2041  Stock Titan

Scienture Secures Crucial Patent Protection for Novel Losartan Oral Suspension Through 2041 - Stock Titan

Click here to get full coverage on Scienture Holdings regains compliance with Nasdaq listing requirements - MSN

Scienture Holdings regains compliance with Nasdaq listing requirements  MSN

Scienture Holdings regains compliance with Nasdaq listing requirements - MSN

Click here to get full coverage on SCIENTURE to commercially launch REZENOPY®, a life-saving opioid overdose emergency treatment through a collaboration with KINDEVA DRUG DELIVERY L.P. - GlobeNewswire

SCIENTURE to commercially launch REZENOPY®, a life-saving opioid overdose emergency treatment through a collaboration with KINDEVA DRUG DELIVERY L.P.  GlobeNewswire

SCIENTURE to commercially launch REZENOPY®, a life-saving opioid overdose emergency treatment through a collaboration with KINDEVA DRUG DELIVERY L.P. - GlobeNewswire

Click here to get full coverage on What drives SCNX stock price - High-profit capital plays - jammulinksnews.com

What drives SCNX stock price - High-profit capital plays  jammulinksnews.com

What drives SCNX stock price - High-profit capital plays - jammulinksnews.com

Click here to get full coverage on Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements - Quiver Quantitative

Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements  Quiver Quantitative

Scienture Holdings, Inc. (SCNX)

Price Chart

Key Statistics

Technicals

About SCNX

Latest News

What insights do SCNX's 2023 earnings reveal about its stability? - AInvest

How many analysts rate SCNX as a “Buy” - Wealth Building Picks That Work - jammulinksnews.com

Scienture Meets $1 Nasdaq Requirement as FDA-Approved Drug Launch Approaches - Stock Titan

Advanced Charts

Top Gainers

Top Losers